These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 68401)

  • 21. Re: "Sex hormone levels in serum in relation to the development of breast cancer".
    Kuller LH; Gutai JP
    Am J Epidemiol; 1988 Jan; 127(1):201-2. PubMed ID: 3337075
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
    Secreto G; Recchione C; Cavalleri A; Miraglia M; Dati V
    Br J Cancer; 1983 Feb; 47(2):269-75. PubMed ID: 6824571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DIANA trials on diet and endogenous hormones.
    Berrino F; Bellati C; Ooldani S; Mastroianni A; Allegro G; Berselli E; Venturelli E; Cavalleri A; Cambié M; Pala V; Pasanisi P; Secreto G
    IARC Sci Publ; 2002; 156():439-44. PubMed ID: 12484231
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
    Bird CE; Cook S; Owen S; Sterns EE; Clark AF
    Oncology; 1981; 38(6):365-8. PubMed ID: 6795556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating hormone concentrations in women with breast cancer.
    McFadyen IJ; Forrest AP; Prescott RJ; Golder MP; Groom GV; Fahmy DR; Griffiths K
    Lancet; 1976 May; 1(7969):1100-2. PubMed ID: 57508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hormones in human breast cancer subjects.
    Krishnamoorthy G; Govindarajulu P; Ramalingam V
    Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgens and breast cancer.
    Kotsopoulos J; Narod SA
    Steroids; 2012 Jan; 77(1-2):1-9. PubMed ID: 22015396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlations between PRL and 17-beta-E in human breast cancer].
    Larrad Jiménez A; Ruiz-Tartas A; Zapatero Gaviria J; López Lazareno N
    Rev Esp Oncol; 1984; 31(2):279-87. PubMed ID: 6549590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy in breast cancer.
    Kahán Z
    Ther Hung; 1992; 40(4):154-62. PubMed ID: 1345021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical and endocrine study of Anandron (RU-23908) in advanced post-menopausal breast cancer.
    Millward MJ; Cantwell BM; Dowsett M; Carmichael J; Harris AL
    Br J Cancer; 1991 May; 63(5):763-4. PubMed ID: 1903951
    [No Abstract]   [Full Text] [Related]  

  • 32. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
    Ravdin PM; Fritz NF; Tormey DC; Jordan VC
    Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
    Yasumura T; Oka T; Honjo H; Okada H
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgens and breast cancer in premenopausal women.
    Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
    Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estradiol binding by serum proteins in the postmenopause of women with breast cancer].
    Nikolov IT; Dimitrov OA
    Probl Endokrinol (Mosk); 1990; 36(5):40-3. PubMed ID: 2080141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial.
    Del Mastro L; Boni L; Michelotti A; Gamucci T; Olmeo N; Gori S; Giordano M; Garrone O; Pronzato P; Bighin C; Levaggi A; Giraudi S; Cresti N; Magnolfi E; Scotto T; Vecchio C; Venturini M
    JAMA; 2011 Jul; 306(3):269-76. PubMed ID: 21771987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].
    Grodecka-Gazdecka S; Baron J
    Ginekol Pol; 1986 Dec; 57(12):778-83. PubMed ID: 3570023
    [No Abstract]   [Full Text] [Related]  

  • 40. The risk of premature menopause induced by chemotherapy for early breast cancer.
    Lower EE; Blau R; Gazder P; Tummala R
    J Womens Health Gend Based Med; 1999 Sep; 8(7):949-54. PubMed ID: 10534297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.